Dubendorff J W, Whittaker L J, Eltman J T, Lipsick J S
Department of Microbiology, School of Medicine, State University of New York at Stony Brook 11794-8621.
Genes Dev. 1992 Dec;6(12B):2524-35. doi: 10.1101/gad.6.12b.2524.
The c-Myb protein plays a key role in normal hematopoiesis, and truncation results in its activation to a transforming protein. Truncation of the c-Myb carboxyl terminus also greatly increases its transcriptional activating activity. The role of specific carboxy-terminal domains in negative regulation was investigated using Myb and Myb fusions with GAL4, LexA, or VP16. Negative regulatory activity of the carboxyl terminus in cis resides in at least two regions. A sequence in one of these regions can also inhibit transcriptional activation by Myb, Myb-VP16, or LexA-Myb proteins in trans. Regulation in trans, or suppression, is independent of c-Myb DNA binding and, therefore, likely involves protein-protein interaction. Suppression does not require the presence of a predicted heptad leucine repeat structure on either molecule. The target of suppression is a sequence that contains part of the minimal Myb transcriptional activation domain. This sequence can confer suppressibility on fusion proteins containing heterologous DNA-binding or transcriptional activation domains.
c-Myb蛋白在正常造血过程中起关键作用,其截短会导致激活成为一种转化蛋白。c-Myb羧基末端的截短也会极大地增加其转录激活活性。使用与GAL4、LexA或VP16融合的Myb和Myb来研究特定羧基末端结构域在负调控中的作用。羧基末端在顺式中的负调控活性至少存在于两个区域。这些区域之一中的一个序列也可以在反式中抑制Myb、Myb-VP16或LexA-Myb蛋白的转录激活。反式调控或抑制独立于c-Myb与DNA的结合,因此可能涉及蛋白质-蛋白质相互作用。抑制并不要求任一分子上存在预测的七肽亮氨酸重复结构。抑制的靶标是一个包含最小Myb转录激活结构域一部分的序列。该序列可以赋予含有异源DNA结合或转录激活结构域的融合蛋白抑制性。